Nell R, Versluis M, Cats D, Mei H, Verdijk R, Kroes W
Sci Rep. 2025; 15(1):8167.
PMID: 40059100
PMC: 11891316.
DOI: 10.1038/s41598-025-90122-z.
Suri P, Badalov A, Ruggiu M
Cancers (Basel). 2025; 17(4).
PMID: 40002189
PMC: 11853465.
DOI: 10.3390/cancers17040594.
Kong L, Chen Z, Jia Z, Deng Q, Zhu P, Xu Y
BMC Genomics. 2025; 26(1):184.
PMID: 39994554
PMC: 11849188.
DOI: 10.1186/s12864-025-11373-8.
Matos P, Jordan P
Cancers (Basel). 2025; 17(2).
PMID: 39858001
PMC: 11764256.
DOI: 10.3390/cancers17020219.
Tzaban S, Stern O, Zisman E, Eisenberg G, Klein S, Frankenburg S
Front Immunol. 2025; 15():1490035.
PMID: 39845971
PMC: 11752881.
DOI: 10.3389/fimmu.2024.1490035.
SF3B1: from core splicing factor to oncogenic driver.
Bak-Gordon P, Manley J
RNA. 2025; 31(3):314-332.
PMID: 39773890
PMC: 11874996.
DOI: 10.1261/rna.080368.124.
Development of single nucleotide polymorphisms in key genes of taurine and betaine metabolism in Crassostrea hongkongensis and their association with content-related traits.
Kong L, Chen Z, Jia Z, Deng Q, Zhu P, Xu Y
Res Sq. 2025; .
PMID: 39764131
PMC: 11702833.
DOI: 10.21203/rs.3.rs-5097219/v1.
Zellweger syndrome; identification of mutations in and gene in Saudi families.
Alayoubi A, Ijaz A, Wali A, Hashmi J, Alharbi A, Basit S
Ann Med. 2025; 57(1):2447400.
PMID: 39757991
PMC: 11705544.
DOI: 10.1080/07853890.2024.2447400.
Role of silent mutations in KRAS -mutant tumors.
Lu J, Zhou C, Pan F, Liu H, Jiang H, Zhong H
Chin Med J (Engl). 2024; 138(3):278-288.
PMID: 39654099
PMC: 11771717.
DOI: 10.1097/CM9.0000000000003405.
In silico splicing analysis of the PMS2 gene: exploring alternative molecular mechanisms in PMS2-associated Lynch syndrome.
Munteanu C, Marian C, Chirita-Emandi A, Puiu M, Trifa A
BMC Genom Data. 2024; 25(1):100.
PMID: 39592919
PMC: 11600730.
DOI: 10.1186/s12863-024-01281-3.
A potential novel role of the R36P mutation in CRYGD in congenial cataract.
Tan C, Yu X, Chen J, Sun X, Wang L
Mol Vis. 2024; 30:260-267.
PMID: 39563676
PMC: 11575838.
Emerging and re-emerging themes in co-transcriptional pre-mRNA splicing.
Carrocci T, Neugebauer K
Mol Cell. 2024; 84(19):3656-3666.
PMID: 39366353
PMC: 11463726.
DOI: 10.1016/j.molcel.2024.08.036.
The Role of RNA Splicing in Liver Function and Disease: A Focus on Metabolic Dysfunction-Associated Steatotic Liver Disease.
Kaminska D
Genes (Basel). 2024; 15(9).
PMID: 39336772
PMC: 11431473.
DOI: 10.3390/genes15091181.
ParSE-seq: a calibrated multiplexed assay to facilitate the clinical classification of putative splice-altering variants.
ONeill M, Yang T, Laudeman J, Calandranis M, Harvey M, Solus J
Nat Commun. 2024; 15(1):8320.
PMID: 39333091
PMC: 11437130.
DOI: 10.1038/s41467-024-52474-4.
Pathogenic relationship between phenotypes of ARPKD and novel compound heterozygous mutations of .
Zhang X, Wu J, Zhou J, Liang J, Han Y, Qi Y
Front Genet. 2024; 15:1429336.
PMID: 39015774
PMC: 11250243.
DOI: 10.3389/fgene.2024.1429336.
Epigenetic control of skeletal muscle atrophy.
Liang W, Xu F, Li L, Peng C, Sun H, Qiu J
Cell Mol Biol Lett. 2024; 29(1):99.
PMID: 38978023
PMC: 11229277.
DOI: 10.1186/s11658-024-00618-1.
Splicing-specific transcriptome-wide association uncovers genetic mechanisms for schizophrenia.
Hervoso J, Amoah K, Dodson J, Choudhury M, Bhattacharya A, Quinones-Valdez G
Am J Hum Genet. 2024; 111(8):1573-1587.
PMID: 38925119
PMC: 11339621.
DOI: 10.1016/j.ajhg.2024.06.001.
Case report: A novel somatic variant in a patient with bladder paraganglioma.
Nguyen T, Ordulu Z, Shrestha S, Patel U, Crispen P, Brown L
Front Endocrinol (Lausanne). 2024; 15:1386285.
PMID: 38911036
PMC: 11190172.
DOI: 10.3389/fendo.2024.1386285.
A new era of mutation rate analyses: Concepts and methods.
Wu K, Qin D, Qian Y, Liu H
Zool Res. 2024; 45(4):767-780.
PMID: 38894520
PMC: 11298668.
DOI: 10.24272/j.issn.2095-8137.2024.058.
Three exonic variants in the gene cause aberrant splicing in a minigene assay.
Pan F, Zhang R, Liu X, Shi X, Xin Q, Qiao D
Front Genet. 2024; 15:1353674.
PMID: 38841723
PMC: 11150636.
DOI: 10.3389/fgene.2024.1353674.